| | |
| 0930 |
10:45 AM | Predictability of Clinical Outcomes Following Regenerative Therapy in Intrabony Defects
M.A. REYNOLDS, and M.E. AICHELMANN-REIDY, University of Maryland, Baltimore, USA |
| 0931 |
11:00 AM | CT and Histomorphometric Evaluation of DBM Putty in Sinus Lifts
Z. SCHWARTZ1, E. RAVIV2, M. GOLDSTEIN3, A. HIRSCH3, M. SUNWOO4, D.M. RANLY3, and B.D. BOYAN3, 1Georgia Institute of Technology, Hebrew University Hadassah, Atlanta, USA, 2Hebrew University Hadassah, Jerusalem, Israel, 3Georgia Institute of Technology, Atlanta, USA, 4Musculoskeletal Transplant Foundation, Edison, NJ, USA |
| 0932 |
11:15 AM | p38 MAP Inhibitors Block LPS-induced Alveolar Bone Loss In Vivo
F. LI1, J. ROGERS1, C. ROSSA2, Y.-J. KIM3, J. KRIEGL1, D. SARMENT1, W. GIANNOBILE1, S. MEDICHERLA4, A. PROTTER4, and K. KIRKWOOD1, 1University of Michigan, Ann Arbor, USA, 2Faculdade de Odontologia de Araraquara - UNESP, University of Michigan, Araraquara SP, Brazil, 3Chonnam National University - Kwangju, University of Michigan, Kwang-Ju, South Korea, 4Scios, Inc, Fremont, CA, USA |
| 0933 |
11:30 AM | RvE1 Protects from Inflammation and Bone Loss in Experimental Periodontitis
H. HASTURK1, A. KANTARCI1, N. EBRAHIMI1, V.L. JONES1, N. PETASIS2, C.N. SERHAN3, and T.E. VAN DYKE1, 1Boston University, MA, USA, 2University of Southern California, Los Angeles, USA, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA |
| 0934 |
11:45 AM | Platelet-Rich Plasma Inhibits Osteoinduction by DBM in Immunocompromised Mice
D. RANLY1, C.H. LOHMANN2, D. ANDREACCHIO2, B.D. BOYAN1, and Z. SCHWARTZ1, 1Georgia Tech Research Institute, Atlanta, USA, 2University of Hamburg-Eppendorf, Germany |
| 0935 |
12:00 PM | Periodontal Therapy Effects on Biomarkers of Systemic Inflammation in Smokers
M.E. RYAN, S. V K ESWARAN, O.I. CARNU, J. FARRELL, R. TENZLER, E. ROEMER, and S. SIMON, Stony Brook University, NY, USA |
|